Biomerica Inc Asset Resilience Ratio
Biomerica Inc asset resilience ratio. Biomerica Inc (BMRA) has an Asset Resilience Ratio of 1.44% as of August 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how many days can Biomerica Inc fund operations to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Biomerica Inc (1999–2018)
Asset resilience ratio of Biomerica Inc from 1999 to 2018. This chart shows how Biomerica Inc's Asset Resilience Ratio has changed over time. Read total liabilities of Biomerica Inc for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Biomerica Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Biomerica Inc total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $165.32K | 1.44% |
| Total Liquid Assets | $165.32K | 1.44% |
Asset Resilience Insights
- Limited Liquidity: Biomerica Inc maintains only 1.44% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Biomerica Inc Industry Peers by Asset Resilience Ratio
Compare Biomerica Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
BMC Medical Co. Ltd. A
SHE:301367 |
Medical Devices | 44.96% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Hironic Co. Ltd
KQ:149980 |
Medical Devices | 17.42% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
Biomerica Inc Asset Resilience Ratio by Year (1999–2018)
Biomerica Inc asset resilience ratio by year from 1999 to 2018. The table below shows the annual Asset Resilience Ratio data for Biomerica Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2018-05-31 | 0.00% | $0.00 | $5.22 Million | -- |
| 2017-05-31 | 0.00% | $0.00 | $5.02 Million | -- |
| 2016-05-31 | 0.00% | $0.00 | $5.73 Million | -- |
| 2015-05-31 | 0.00% | $0.00 | $6.12 Million | -- |
| 2014-05-31 | 0.00% | $0.00 | $6.47 Million | -- |
| 2013-05-31 | 0.00% | $0.00 | $6.39 Million | -- |
| 2012-05-31 | 0.00% | $0.00 | $5.57 Million | -- |
| 2009-05-31 | 1.94% | $100.00K | $5.15 Million | +1.93pp |
| 2008-05-31 | 0.01% | $355.00 | $5.11 Million | -0.01pp |
| 2007-05-31 | 0.02% | $532.00 | $3.22 Million | -0.12pp |
| 2006-05-31 | 0.14% | $3.28K | $2.43 Million | -0.01pp |
| 2005-05-31 | 0.14% | $8.18K | $5.79 Million | -0.33pp |
| 2004-05-31 | 0.47% | $26.12K | $5.57 Million | +0.23pp |
| 2003-05-31 | 0.24% | $13.11K | $5.55 Million | +0.19pp |
| 2002-05-31 | 0.05% | $2.53K | $5.28 Million | -0.73pp |
| 2001-05-31 | 0.78% | $41.57K | $5.35 Million | -0.69pp |
| 2000-05-31 | 1.47% | $98.77K | $6.74 Million | +0.18pp |
| 1999-05-31 | 1.28% | $100.00K | $7.80 Million | -- |
About Biomerica Inc
Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing of diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases in North America, Asia, Europe, the Middle East, and South America. The company offers diagnostic test kits are used to analyze blood, urine, nasal, or fecal material from patients… Read more